Loading data
MBOTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 6.28 m USD | 6.63 m USD | 5.72 m USD | -7.74 m USD | 6.15 m USD |
| Selling, general and administrative expense | 8.46 m USD | 5 m USD | — | — | — |
| Operating profit | -14.74 m USD | -11.63 m USD | -9.86 m USD | -13.28 m USD | -11.36 m USD |
| Net income (reported basis) | -13.14 m USD | -11.44 m USD | -10.74 m USD | -13.17 m USD | -11.31 m USD |
| Basic earnings per share | -0.29 USD/share | -0.73 USD/share | -1.05 USD/share | -1.81 USD/share | -1.59 USD/share |
| Diluted earnings per share | -0.29 USD/share | -0.73 USD/share | -1.05 USD/share | -1.81 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.